Recent Finacing
Recent Raise
NextVivo creates immune-competent 3D organoids preserving organ and immune cell diversity and spatial organization to support preclinical testing of cell, antibody and drug candidates for cancer and autoimmune disease.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at NextVivo.
